Page last updated: 2024-10-30

mesalamine and Long Sleeper Syndrome

mesalamine has been researched along with Long Sleeper Syndrome in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"Older ulcerative colitis (UC) patients had similar anti-TNF use (16."1.43Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease. ( Anton, K; Chen, W; Geisz, M; Ha, C; Kappelman, MD; Long, MD; Martin, CF; Sandler, RS, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geisz, M1
Ha, C1
Kappelman, MD1
Martin, CF1
Chen, W1
Anton, K1
Sandler, RS1
Long, MD1

Other Studies

1 other study available for mesalamine and Long Sleeper Syndrome

ArticleYear
Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease.
    Inflammatory bowel diseases, 2016, Volume: 22, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anxiety;

2016